Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

Recent randomized controlled trials (RCTs) tested the efficacy of sodium-glucose cotransporter-2 (SGLT-2) inhibitors to specifically treat nonalcoholic fatty liver disease (NAFLD). We systematically searched three electronic databases (up to 31 October 2020) for identifying placebo-controlled or hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantovani, Alessandro, Petracca, Graziana, Csermely, Alessandro, Beatrice, Giorgia, Targher, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823667/
https://www.ncbi.nlm.nih.gov/pubmed/33396949
http://dx.doi.org/10.3390/metabo11010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823667/
https://www.ncbi.nlm.nih.gov/pubmed/33396949
http://dx.doi.org/10.3390/metabo11010022

Ejemplares similares